Medipal Holdings (TSE:7459) Marketable Securities: 円0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7459 Medipal Holdings Corp TSE:7459
82 GF Score
Price 円2,817.00
GF Value 円2,736.76
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Medipal Holdings Marketable Securities?

Medipal Holdings TSE:7459 -2.29% 82 Marketable Securities is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:7459 with a GF Score™ of 82/100 and a GF Value™ of 円2,736.76 (Fairly Valued). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Medipal Holdings's Marketable Securities for the quarter that ended in Mar. 2026 was 円0 Mil.

Medipal Holdings's annual Marketable Securities declined from Mar. 2024 (円316 Mil) to Mar. 2025 (円0 Mil) but then stayed the same from Mar. 2025 (円0 Mil) to Mar. 2026 (円0 Mil).

Medipal Holdings  (TSE:7459) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Medipal Holdings Marketable Securities Related Terms

Medipal Holdings Marketable Securities Historical Data

* Premium members only.

The historical data trend for Medipal Holdings's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medipal Holdings Marketable Securities Chart

Medipal Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18,770.00 0.00 316.00 0.00 0.00

Medipal Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:7459
82GF Score
Medipal Holdings Corp TSE:7459
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medipal Holdings Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of 円0 Mil mean?
Medipal Holdings (TSE:7459) has a Marketable Securities of 円0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Medipal Holdings and its competitors.
Is Medipal Holdings' Marketable Securities too high?
Medipal Holdings' current Marketable Securities is 円0 Mil. Overall, Medipal Holdings has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Marketable Securities compare to MCK and COR?
Medipal Holdings' Marketable Securities of 円0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Distribution company?
A good Marketable Securities depends on the Medical Distribution industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Medipal Holdings and its competitors. Medipal Holdings's current Marketable Securities is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (TSE:7459) is currently considered Fairly Valued. The stock's GF Value™ is 円2,736.76, compared to a current price of 円2,817.00 — trading 2.9% above its estimated fair value. The current Marketable Securities is 円0 Mil. Medipal Holdings' overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Medipal Holdings (TSE:7459), the current Marketable Securities is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medipal Holdings (TSE:7459) Overvalued in 2026?

Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued. The current stock price of 円2,817.00 is trading 2.9% above its estimated GF Value™ of 円2,736.76. GuruFocus considers Medipal Holdings to be Fairly Valued.

Key valuation signals for TSE:7459:

  • Marketable Securities: 円0 Mil
  • GF Value™: 円2,736.76 vs. price of 円2,817.00 (2.9% above fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the TSE:7459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medipal Holdings Business Description

Other Exchanges MEPDF:USAMAHLY:USA
Address 3-1-1 Kyobashi, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
82GF Score

Get the complete analysis for TSE:7459

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,817.00
Price
円2,736.76
GF Value